Is Connect Biopharma Holdings Ltd (CNTB) overvalued? · rev $26.0M
Connect Biopharma Holdings Ltd (CNTB) is a biotechnology company listed on US.
This page asks whether Connect Biopharma Holdings Ltd (CNTB) looks expensive on cached numbers — not a short thesis.
Latest reported CNTB revenue for 2024-12-31 was $26.0M. Net income was -$15.6M. CNTB currently screens at market cap $63.3M.
CNTB currently screens at market cap $63.3M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next CNTB 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the CNTB stock page for the full model, not this heading.
Not investment advice.